Drug intelligence / Profile preview

jianpibushenhuoxuefang

Development stage: Preclinical
Lead developer: Beijing Municipal Administration of Traditional Chinese Medicine
Administration: Oral

Overview

Jianpibushenhuoxuefang is a Traditional Chinese Medicine (TCM) formula, also referred to as a modified Yulin Decoction. Its name translates to "Invigorating spleen and kidney and activating blood circulation," indicating its traditional actions within TCM principles. It is being investigated for its therapeutic potential in conditions such as Premature Ovarian Failure.

Other names: Invigorating spleen and kidney and activating blood circulationInvigorating the spleen and kidney and promoting blood circulationmodified Yulin Decoction

Beyond the preview

Go deeper on jianpibushenhuoxuefang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on jianpibushenhuoxuefang.

Explore the full profile